INTRODUCTION
Fibrosis is the pathological deposition of extracellular matrix (ECM) associated with persistent inflammation. The contribution of the hematopoietic system to this process has been widely investigated, and numerous leukocyte subsets are implicated in driving fibrotic remodeling, including M2 macrophages, neutrophils, eosinophils, mast cells, and lymphocytes (1, 2) . In particular, type 2 immune responses have long been associated with tissue fibrosis, and interleukin-4 (IL-4) and IL-13 signaling has been shown to drive tissue remodeling and ECM deposition in the liver in response to Schistosoma mansoni infection (3) . In mucosal tissues, both CD4 + T helper 2 (T H 2) and T H 17 cells have been linked to the development of tissue fibrosis. For example, in a mouse model of chronic gut inflammation and fibrosis, an overlapping production of IL-13 and IL-17A coincides with the appearance of fibrotic tissue, which suggests that the pathology may be driven by a mixed T H 2 and T H 17 response (4) .
Innate lymphoid cells (ILCs) are a recently identified subset of leukocytes and a prominent source of cytokines with profiles similar to those of T H cells, yet these cells lack antigen-specific receptors and their temporal production of cytokines precedes adaptive immune responses. ILCs can be classified on the basis of their transcript and cytokine profiles; for instance, group 2 ILCs (ILC2s) are GATA3-and RORa (retinoic acid receptor-related orphan receptor a)-dependent and produce IL-5 and IL-13, whereas group 3 ILCs (ILC3s) express RORgt and are a source of IL-17A and IL-22. ILCs have broad functions in host defense responses against pathogens, maintenance of tissue homeostasis, and pathologies, such as allergic asthma and colitis (5) . Recently, ILC2s were shown to have the capacity to drive excessive lung collagen deposition; likewise, analyses of idiopathic pulmonary fibrosis patient bronchoalveolar lavage fluid revealed an expansion of ILC2s, providing correlative evidence that ILCs may be pathogenic in fibrotic remodeling (6) . Despite their pathogenic role in these models, ILC2s have also been shown to play a critical role in tissue repair. For example, in mouse models of lung influenza infection (7) and dextran sulfate sodium-induced colitis (8) , ILC2s aid tissue repair through their production of amphiregulin. Similarly, ILC3s in the gut demonstrate protective or pathogenic roles depending on context. ILC3s are necessary for pathogen clearance (9, 10) and gut tissue repair after chemotherapy-induced injury. This is likely through IL-22-dependent activation of epithelial progenitors (11) , but ILC3s can also promote intestinal tumor formation in a chronic inflammatory setting (12) . In summary, there are data to support both beneficial and pathogenic roles for ILC2s and ILC3s in tissue remodeling.
Crohn's disease (CD) is primarily characterized as a T H 17-driven disease (13) , and distinct IL-23-dependent ILCs that produce IL-17A and IL-22 are also elevated in CD patient samples (14, 15) , arguing for a role for T H 17 cytokines. Conversely, other studies have suggested that ILC2s and eosinophils are contributing factors to CD progression through an IL-13-dependent accumulation of matrix-producing fibroblasts (16, 17) . Thus, there is evidence to support both T H 2 and T H 17 responses in the pathology of CD. However, the direct involvement of ILCs in driving excessive tissue remodeling and, ultimately, fibrosis in the gut remains unclear.
RORa is a transcription factor known to regulate ILC2 development. It is closely related to RORgt, which is a critical regulator of T H 17 and ILC3 subsets, including lymphoid tissue inducer cells (18) (19) (20) . Moreover, in the T H 17 lineage, RORgt and RORa are coexpressed and function synergistically for lineage maintenance and cytokine production (21) . Previously, we showed that Rora sg/sg bone marrow transplant (BMT) chimeric mice provide a suitable model of ILC2 deficiency because they selectively lack ILC2s, whereas other leukocyte lineages, including other ILCs, are present at steady state (22) . Furthermore, Rora sg/sg BMT animals are protected from type 2 immune lung pathology (22) (23) (24) . Here, we used a similar strategy to evaluate their role in a Salmonella-induced model of gut fibrosis. We show that RORa is required for a fibrotic response. Unexpectedly, this is not through regulation of ILC2-dependent production of type 2 cytokines, but rather through a previously unrecognized role for RORa in the production of cytokines from ILC3s. We also found that restoration of ILCs in Rora sg/sg BMT mice is sufficient to reestablish susceptibility to fibrotic disease. These data provide evidence that ILC3s contribute to fibrosis and offer RORa as a new therapeutic target for fibrotic tissue remodeling.
RESULTS

Salmonella-induced gut pathology was dependent on hematopoietic expression of RORa
We generated Rora sg/sg BMT mice and evaluated how they respond to infection with the DaroA strain of Salmonella Typhimurium, which induces robust ECM deposition in the cecum (25) . We found no differences in pathogen burdens in the ceca or spleens of wild-type (WT) BMT and Rora sg/sg BMT mice at days 7, 21, and 35 post-infection (pi), indicating that Rora is dispensable for Salmonella clearance (Fig.  1A ). In addition, we found similar degrees of mucosal thickening, edema, and inflammatory infiltrates in these animals at day 7 pi (Fig. 1B) . In contrast, at 21 days pi, during peak fibrosis, we observed pronounced epithelial cell hyperplasia and pathological remodeling of normal tissue architecture, including disruption and thickening of the basal lamina in WT BMT ceca, whereas we found a notable attenuation in collagen deposition and dampened immunopathology in cecal sections of Rora sg/sg BMT mice. Similarly, by day 35 pi, much of the pathology and inflammation was resolved in Rora sg/sg BMT mice, with mucosa thickness returning to levels similar to uninfected samples (albeit with some residual collagen in the submucosal regions) (Fig. 1B) . Conversely, WT BMT cecal sections revealed persistent tissue inflammation and lymphoid cell aggregates at this time point (Fig. 1, B and C) .
In evaluating cytokine production, we found that Tnfa and Il6 transcripts are present at similar levels at day 7 pi but were significantly reduced in Rora sg/sg BMT cecal samples at the day 21 and 35 time points (Fig. 1D) . Consistent with these mRNA results, quantification of cytokines in cecal homogenates revealed significantly less TNF (tumor necrosis factor), IL-6, MCP-1 (monocyte chemoattractant protein-1), and IL-10 [but comparable levels of IL-12p70 and IFN-g (interferon-g)] in Rora sg/sg BMT samples when compared with their WT BMT counterparts at day 21 pi (Fig. 1E) . In summary, we found that deletion of Rora leads to attenuated inflammatory responses associated with fibrosis, and these correlated with a more rapid resolution of immunopathology and tissue architecture during the late phases of chronic Salmonella infection.
Fibrosis was attenuated in Rora sg/sg BMT mice during chronic infection Consistent with a role for RORa in driving fibrosis, we found significantly reduced levels of Col1a2 and Tgfb1 transcripts and TGF-b1 (transforming growth factor-b) protein in Rora sg/sg BMT ceca at days 21 and 35 pi (Fig. 2, A and B) . Immunofluorescence staining for type 1 collagen (Col1) in WT BMT tissues indicated that the most pronounced collagen deposition occurred in the submucosal region of the cecum, with more modest accumulation in the mucosa, 21 and 35 days pi. There was less submucosal Col1 staining in the Rora sg/sg BMT ceca (Fig. 2C) as quantified by evaluation of the fold change Transcript levels of proinflammatory cytokines Tnfa and Il6 in ceca normalized to Gapdh. Tnfa: *3, P = 0.022 (n = 5 per group); *4, P = 0.027 (n = 5 or 6 per group); Il6: *5, P = 0.002 (n = 5 per group); *6, P = 0.032 (n = 11 or 13 per group; data from two independent experiments). (E) Protein levels of TNF, IL-6, MCP-1, IFN-g, IL-12p70, and IL-10 in naïve and 21-day pi cecal homogenates as determined by cytometric bead array normalized to total tissue protein. *7, P = 0.0017; *8, P = 0.012; *9, P = 0.0010; *10, P = 0.040 (n = 10 or 11; data from two independent experiments). Significance was determined by unpaired Student's t test. UI, uninfected.
increase in surface area of submucosal Col1 staining normalized to total tissue surface area (Fig. 2D ). Consistent with these findings, we also observed reduced type 3 collagen (Col3) staining in the submucosal regions of the cecum of Rora sg/sg BMT mice compared with WT BMT tissue (Fig. 2E) . Last, we visualized fibroblast accumulation at day 21 pi by staining for the common fibroblast markers vimentin and desmin (25) . We found substantial accumulation of vimentin-and desmin-positive cells across the mucosal and submucosal regions of WT BMT ceca; desmin staining was particularly enriched within the basal lamina, which was thicker in WT than in Rora sg/sg BMT samples (Fig. 2F) . Quantification of vimentin-and desmin-positive cells in these immunofluorescent images revealed a reduction in fibroblast numbers in Rora sg/sg BMT cecum compared with WT BMT tissues (Fig. 2G) . Together, our results indicate that, by all criteria, Rora sg/sg BMT animals are protected from fibrosis with reduced collagen and fibroblast accumulation in the cecum.
Eosinophils and STAT6 signaling were dispensable in Salmonella-induced fibrosis Chronic Salmonella infection is known to induce a T H 1/T H 17 response (25) , but the contribution of type 2 immune cell cytokines in this model has not been thoroughly addressed. However, in our cytokine analysis, we found that IL-5 and IL-13 transcript levels in fibrotic WT BMT cecal tissues were similar to infected tissues of Rora sg/sg BMT animals and were reduced or unaltered when compared with uninfected samples ( fig. S1A ). Although we found that absolute numbers of ILC2s and eosinophils in WT BMT cecal samples expand in response to Salmonella infection, and were significantly reduced in Rora sg/sg BMT samples, the relative proportions of ILC2s and eosinophils (as T H 2 effector cells) normalized to all CD45 + cells were reduced or unchanged during peak fibrosis when compared with naïve controls ( fig. S1 , B and C). Thus, these data argue against a major role of ILC2s in this fibrotic response.
To further rule out a role of T H 2 immunity in Salmonella-induced fibrosis, we infected eosinophil-deficient DdblGATA mice. These studies revealed similar pathogen burdens in the cecum and spleen (Fig. 3A) , as well as comparable evidence of pathology in Masson's trichrome (MT)-stained cecal sections of infected animals ( Fig. 3 , B and C). Transcript quantification also revealed similar levels of Col1a2, Tnfa, and Il6 in the eosinophil-deficient tissues, although Tgfb1 and Epx transcripts were significantly reduced (Fig. 3D) . We conclude that eosinophils are dispensable in this model.
In many examples of fibrosis, signal transducer and activator of transcription 6 (STAT6) plays an essential role as a transcriptional mediator of downstream IL-4/IL-13 receptor signaling involved in the propagation of other type 2 immune cells (1). After infection with Salmonella, we found that Stat6 −/− and WT animals exhibited similar pathogen burdens in the cecum and the spleen (Fig. 3E ) and displayed a similar degree of pathology in the cecum (Fig. 3 , F and G). Furthermore, we observed comparable levels of Col1a2, Tgfb1, Tnfa, and Il6 expression in both WT and Stat6 −/− cecal tissues (Fig. 3H ). In aggregate, our data indicate that eosinophils and STAT6/T H 2 effector function signaling are dispensable for Salmonella-induced gut fibrosis.
RORa mediates IL-17A and IL-22 production in chronic gut inflammation and fibrosis Although Rora sg/sg BMT mice are known to have a profound defect in ILC2 development (22, 26) , one previous study indicated that RORa is also required by T H 17 cells for normal cytokine production (21) . In addition, although Rora sg/sg BMT animals have normal ILC3 numbers in the small intestine and mesenteric lymph nodes (mLNs) at steady state (22) , several studies have detected high Rora transcript levels in gut ILC3s (27, 28) or ILC3-like subsets (29, 30) . Despite these observations, the importance of RORa expression in regulating ILC3s in the context of inflammatory diseases is unknown. We therefore evaluated T H 17 and ILC3-associated cytokines in infected Rora sg/sg BMT ceca. These mice exhibited a decrease in cecal Il17a and Il22 transcripts at days 21 and 35, as well as a corresponding reduction in IL-17A and IL-22 protein in cecal homogenates (Fig. 4, A and B) . Consistent with this observation, we previously reported significantly reduced levels of IL-17A in the lungs of Rora sg/sg BMT mice in both ovalbumin-and house dust mite-induced models of allergic disease (23). We conclude that T H 17-biased immune responses are highly attenuated in RORa-deficient mice.
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Next, we characterized IL-17A-and IL-22-producing mLN populations by flow cytometry (fig. S2 ). Total mLN ILC3 numbers were comparable in WT and Rora sg/sg BMT mLNs at 21 days pi (Fig. 4C ). Despite their normal frequency, we found highly attenuated IL-17A and IL-22 production in ILC3s of Rora sg/sg BMT mice (Fig. 4D) . This was further supported by evaluation of residual, radioresistant WT ILC3 present in the mLN of Rora sg/sg BMT chimeric mice. These cells represented roughly 10% of the mLN ILC3 as determined by allotype marker staining and produced normal levels of IL-17A and IL-22 (Fig. 4D ). This suggests that defective cytokine production by Rora sg/sg ILC3s is cell-intrinsic and independent of potential alterations in the composition of the inflammatory environment. Consistent with previous characterization of RORa in T H 17 cells (21), Rora sg/sg CD3 + T cells isolated from mLNs of infected animals have reduced IL-17A but unaltered IL-22 production compared with WT T cells (Fig. 4E) . Peripheral blood analyses of BM chimeras revealed 90% donorderived CD45.2 + cells and 10% CD45.1 + radioresistant host-derived cells (Fig. 4F) . More selective analyses of IL-17A + mLN cells in WT BMT mice revealed 73% IL-17A + cell chimerism, suggesting that there is a subset of tissue-specific, radioresistant IL-17A-producing cells (Fig.  4F) . These cells were more frequent in Rora sg/sg BMT chimeras, with only~55% of total IL-17A + cells originating from donor BM cells. Host and donor contributions to IL-22 + cells in both WT and Rora sg/sg BMT mice overlapped with their respective peripheral blood chimerism, indicating a lack of IL-22 + cell enrichment in the tissue-resident, radioresistant population (Fig. 4F) . Consistent with mLN cell analyses, ILC3s isolated from the ceca of Rora sg/sg BMT mice have reduced IL-17A and IL-22 production compared with WT BMT ILC3s (Fig.  4G) ; RORa-deficient cecal CD3 + T cells also display attenuated IL-17A but normal IL-22 expression (Fig. 4H) . In summary, we conclude that there is a defect in cytokine production by T H 17 and ILC3 cells in Rora sg/sg BMT mice.
Salmonella-induced gut fibrosis is dependent on Rora + ILC3 To further evaluate the ILC-versus T H cell-dependent contributions to fibrosis in our experimental model, we generated mixed BM chimeras by reconstituting lethally irradiated mice with equal numbers of BM cells from Rag1 −/− mice combined with either WT or Rora sg/sg BM cells. The rationale was that cotransplanting Rag1 −/− and Rora sg/sg BM cells would restore normal ILC3s (Rag1 −/− -derived) without altering the Rora sg/sg -derived T cell compartment. At 21 days pi, we found that cecal and splenic Salmonella burdens in these mice were similar (Fig. 5A) . MT-stained cecal tissues from these Rag1 −/− /Rora sg/sg BMT animals revealed immunopathology and fibrosis comparable to Rag1 −/− /WT BMT animals (Fig. 5B) , including a similar degree of epithelial cell hyperplasia, inflammatory infiltrates, and collagen deposition in the submucosal regions, which was represented in the pathology scores (Fig. 5C ). Further, we found similar transcript levels of Col1a2, Tgfb1, Tnfa, and Il6 in infected ceca of Rag1 
/Rora
sg/sg BMT animals (Fig. 5D ). Quantification of IL-17A and IL-22 in cecal homogenates indicated that these cytokines were restored to comparable levels in Rag1 
sg/sg BMT samples (Fig. 5E ). In summary, these data argue that Rora-expressing ILC3s are sufficient to cause fibrosis.
Last, to determine whether IL-17A is a critical profibrotic factor in this model, we treated Salmonella-infected mice with neutralizing antibodies against IL-17A. Although we found that the Salmonella burdens in the spleens and the ceca of isotype control and anti-IL-17A-treated mice were unaltered (Fig. 6A) , we observed reduced pathology in the ceca of animals treated with antibodies against IL-17A (Fig. 6B ) because MT-stained cecal sections exhibited an attenuation in epithelial remodeling and fibrotic scarring (Fig. 6C) . Moreover, IL-17A neutralization resulted in a decrease in submucosal collagen accumulation (Fig. 6D) . Our results indicate that fibrosis during the late phases of chronic Salmonella infection is IL-17A-dependent.
DISCUSSION
This report provides insights into Rora-dependent immune function and Crohn's-like fibrotic disease ( fig. S4 ). Using a model of Salmonellainduced intestinal fibrosis, we find that hematopoietic deletion of Rora protects animals from fibrogenesis in the gut. Assessment of tissue pathology and cytokine analysis during the prefibrotic phase at day 7 pi suggests that early inflammatory responses were comparable in WT and Rora sg/sg BMT animals. Furthermore, Salmonella burdens in the gut and spleen during initial colonization were unaltered by hematopoietic Rora expression. These observations suggest that RORa does not influence initial inflammatory responses, or the host's ability to clear the infection, but rather plays a specific role in generating a profibrotic response in the gut during late stages of chronic Salmonella infection. The apparent disconnect between bacterial colonization and the severity of fibrosis is consistent with previous reports that demonstrate that intestinal fibrosis does not require the presence of Salmonella as a persistent inflammatory stimulus (31, 32) . Instead, the pathology becomes self-propagating and is largely irrespective of interventions that attempt to reduce pathogen burdens or repress early inflammatory responses.
Although gut fibrosis that develops after chronic Salmonella infection strongly correlates with a T H 17 response (25), we initially sought to examine the contributions of type 2 immune cell-associated cytokines in fibrosis. This is relevant for several reasons. First, in a mouse model of trinitrobenzene sulfonic acid-induced colitis, peak IL-4 and IL-13 cytokine levels were reported during the late phases of inflammation and were associated with tissue remodeling and fibrosis (4). Second, ILC2s are well known to recruit eosinophils by their secretion of IL-5 (33); eosinophilia has been linked previously to stricture complications in CD patients, and IL-13 has been reported to promote gut fibroblast activation (16) . Therefore, although it is likely that ILC2s are irrelevant during the early phase of Salmonella infection, their role in downstream fibrotic remodeling has not been thoroughly investigated. Although we observed a profound attenuation in collagen deposition in infected Rora sg/sg BMT ILC2-deficient animals, IL-13 and IL-5 levels were not markedly altered in fibrotic gut tissue when compared with uninfected controls. Furthermore, we find that fibrosis is not diminished in cecal tissues of infected DdblGATA or Stat6 −/− mice, suggesting that eosinophils and STAT6 signaling as mediators of T H 2 effector cell functions are dispensable for Salmonella-induced fibrosis. These findings argue strongly for a T H 2/ILC2-independent role for RORa in fibrosis. In examining other eosinophil-derived factors previously implicated in inflammatory bowel disease, the reduction in Epx1 was fully expected because infected DdblGATA mice lack eosinophils and, therefore, this selective marker. Eosinophils are also a well-known source of TGF-b1, and therefore, it is perhaps not surprising that its production is lower in these animals. The fact that loss of eosinophils as a source of TGF-b1 has no effect on the fibrotic outcome, however, is intriguing. One could argue that the residual levels of TGF-b1 that we observe in the eosinophil-deficient mice are necessary but not sufficient to induce fibrosis and that a second signal is required. On the basis of our antibody suppression experiments, we would argue that IL-17A is one such factor and a critical driver of fibrotic disease.
Consistent with a previous report identifying RORa as an important transcriptional mediator of T H 17 cell cytokine production (21), we find that IL-17A and IL-22 levels were diminished in infected cecal tissue of Rora sg/sg BMT mice compared with WT samples. Normal IL-17A and IL-22 production by ILC3s is Rora-dependent, whereas IL-17A expression by T cells is also impaired in Salmonella-infected Rora sg/sg BMT animals. This defect in cytokine production by RORa- Although we have shown that antibody-mediated neutralization of IL-17A protects against fibrosis in a Salmonella-induced model, the clinical importance of these findings may be questioned because anti-IL-17A antibody treatment failed as a therapy in patients with CD due to lack of efficacy and adverse side effects (34) . However, CD manifests itself in many ways, and fibrosis is only detected in a subset of these patients. Importantly, patients with "stricture causing obstructive symptoms" were excluded from this clinical trial. With this in mind, we would argue that the effects of anti-IL-17A on stricture formation and maintenance in humans remain an open question and that further study is justified.
Although RORa and RORgt are related members of a subfamily of nuclear orphan receptors, each has distinct and some overlapping functions in hematopoietic development. Unlike Rorc deletion, which ablates ILC3s and T H 17 cells, the effect of Rora deletion on these subsets appears to be far more subtle and limited to an attenuation of cytokine production. There has been strong interest in developing RORgt inhibitors as a therapy for T H 17-or ILC3-mediated disorders (35) (36) (37) . However, there are some concerns with this strategy because RORgt + regulatory T cells were found to be critical in limiting disease severity in experimental colitis (38, 39) . Moreover, RORgt regulates thymocyte differentiation, and aged Rorc −/− mice exhibit a very high frequency of T cell lymphoma (40) . Our findings argue that RORa may serve as a more attractive therapeutic target for CD-associated fibrosis and that development of selective inhibitors of RORa (that spare RORgt) is warranted.
MATERIALS AND METHODS
Study design
Our aim was to investigate the role of RORa-dependent immunity in gut fibrotic responses. We used a BMT model for hematopoietic Rora deficiency in mice, as well as other conventional mutant knockout strains in a chronic infection model of intestinal fibrosis. Age-and sexmatched mice were randomly divided into recipient groups for BM transplantation. Infection experiments included four to eight mice per group and were performed at least two times with the exception of experiments pertaining to Stat6 −/− mice (Fig. 3 , E to H), which were from a single experiment. 
Infection model
Mice were treated with 20 mg of streptomycin by oral gavage 24 hours before oral infection with 3 × 10 6 S. Typhimurium DaroA colonyforming units (CFU) in 100 ml of phosphate-buffered saline (PBS). At various time points, tissues were collected and homogenized in sterile PBS; serial dilutions of the homogenates were plated on LB agar plates [streptomycin (100 mg/ml)] for bacterial enumeration. For IL-17A-neutralizing experiments, mice were injected intraperitoneally with 200 mg of antibodies against IL-17A (Janssen, CNTO 8096) or isotype control (Janssen, CNTO 2407) three times per week beginning at 7 days after infection and killed at day 21 pi for tissue collection.
Histology and immunohistochemistry
Formalin-fixed and paraffin-embedded tissues were cut into 5-mm sections for MT staining. Cecal pathology was scored as previously described (25) . For immunostaining, tissue sections were deparaffinized and rehydrated and underwent antigen retrieval; antibodies against Col1 (Abcam), type 3 collagen (Fitzgerald), vimentin (Abcam), and desmin (Santa Cruz Biotechnology) were used, followed by incubation with Alexa Fluor-conjugated secondary antibodies (Life Technologies). Sections were then mounted using ProLong Gold Antifade with 4′,6-diamidino-2-phenylindole (DAPI) (Life Technologies). Optical z-stack images were captured on a Leica SP5 X confocal microscope and analyzed using ImageJ.
Quantitative reverse transcription polymerase chain reaction Total RNA extracted from terminal ends of cecal tissue using TRIzol (Invitrogen) was reverse-transcribed with a high-capacity complementary DNA reverse transcription (RT) kit (Thermo). Quantitative real-time polymerase chain reaction (PCR) was performed using SYBR Green chemistry (KAPA) and gene-specific primer pairs (table S1) on an AB7900 RT-PCR system.
Cytokine detection
Concentrations of TNF, IL-6, MCP-1, IFN-g, IL-12p70, IL-10, and IL-17A in cecal homogenates were determined using a cytometric bead array (BD Biosciences); TGF-b1 and IL-22 levels were determined by plate enzyme-linked immunosorbent assay kits (eBioscience) according to the manufacturer's instructions.
Immunoanalyses and flow cytometry mLNs were excised and passed through a 70-mm filter to generate single-cell suspensions. Leukocytes were isolated from ceca by flushing luminal contents and mincing and incubating tissues in collagenase D (1.5 U/ml) and dispase II (2.4 U/ml) (Roche) for 30 min at 37°C with gentle rotation. Samples were then passed through a 70-mm filter, and hematopoietic cells were enriched by Percoll (GE) separation. The cells were restimulated using phorbol 12-myristate 13-acetate (PMA) (50 ng/ml) and ionomycin (750 ng/ml) (Sigma) in the presence of brefeldin A (eBioscience) for 4 hours. Samples were then incubated with anti-CD16/ 32 (5 mg/ml) (2.4G2, in-house) to block nonspecific antibody binding. Fluorescence-conjugated antibodies to CD45.2 (104), CD8 (53.67), CD11b (M1/70), CD11c (N418), CD19 (1D3), NK1.1 (PK136), Gr1 (RB6-8C5), Ter119, CD3e (145-2C11), CD90.2 (30-H12), KLRG1 (2F1), Sca-1 (D7), IL-17A (eBio17B7), and IL-22 (1H8PWSR) were used. A fixation and permeabilization buffer set (eBioscience) was used for intracellular cytokine staining, and a fixable viability dye (eBioscience) was used for dead cell exclusion. Data were acquired on a BD LSR II and analyzed using FlowJo.
Statistics
Results are presented as means ± SEM; statistical significance was determined by unpaired Student's t test.
SUPPLEMENTARY MATERIALS
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